Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study

Area of Science:

• Pediatric Hematology Oncology
• Cancer Genetics
• Cell Biology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous cancer.
• Understanding the cellular origins and genetic landscape of ALL is crucial for diagnosis and treatment.
• Clonal chromosomal abnormalities are hallmarks of cancer, but their presence in non-leukemic cell lineages in ALL is not fully understood.

Purpose of the Study:

• To investigate the presence of clonal chromosomal abnormalities in myeloid cell lineages within bone marrow aspirates of children diagnosed with ALL.
• To determine if these abnormalities extend beyond the leukemic lymphoid blasts to other hematopoietic cell types.

Main Methods:

• Utilized a combination of Morphology, Antibody staining, and Chromosome analysis (MAC) techniques.
• Employed in situ hybridization procedures for detailed genetic analysis.
• Analyzed bone marrow aspirates from six pediatric patients with ALL.

Main Results:

• Chromosomal aberrations were identified in CD10- and CD20/22-positive lymphoid cells of patients with lymphoid-only ALL.
• Mature lymphocytes (CD22+ and CD3+) did not exhibit these chromosomal aberrations.
• In one patient with mixed lymphoid and myeloid-associated antigen expression, clonal aberrations were present in CD10+ and CD19+ blasts, as well as in glycophorin A-positive, morphologically nonleukemic erythroblasts.

Conclusions:

• Clonal chromosomal abnormalities in pediatric ALL can be present in lymphoid progenitor cells.
• The findings suggest a potential shared clonal origin or early divergence event between lymphoid and myeloid lineages in some ALL cases.
• Further research is needed to elucidate the implications of these findings for ALL pathogenesis and clinical management.